Skip to main content
Clinical Trials/NCT01376531
NCT01376531
Completed
Not Applicable

Influence of Continuous Veno-venous Hemodialysis on Cerebrovascular Autoregulation in Patients With Acute Renal Failure

Johannes Gutenberg University Mainz1 site in 1 country20 target enrollmentJanuary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Renal Failure
Sponsor
Johannes Gutenberg University Mainz
Enrollment
20
Locations
1
Primary Endpoint
Change from Baseline cerebrovascular autoregulation to cerebrovascular autoregulation during continuous veno-venous hemodialysis
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The aim of the study is to characterize the influence of continuous veno-venous hemodialysis on the cerebrovascular autoregulation.

Detailed Description

Patients at the intensive care unit who suffered acute renal failure with the need of continuous veno-venous hemodialysis will be investigated with continuous veno-venous hemodialysis and in a time window without continuous veno-venous hemodialysis to investigate the influence of continuous veno-venous hemodialysis on the cerebrovascular autoregulation.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
June 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Johannes Gutenberg University Mainz
Responsible Party
Principal Investigator
Principal Investigator

Patrick Schramm

Senior Physician

Johannes Gutenberg University Mainz

Eligibility Criteria

Inclusion Criteria

  • acute renal failure
  • need for continuous veno-venous hemodialysis
  • age \>18 Years

Exclusion Criteria

  • Preexisting cerebral illness
  • traumatic brain injury
  • Meningitis or encephalitis
  • Pregnancy

Outcomes

Primary Outcomes

Change from Baseline cerebrovascular autoregulation to cerebrovascular autoregulation during continuous veno-venous hemodialysis

Time Frame: 1 Year

Is there an influence of continuous veno-venous hemodialysis at the cerebrovascular autoregulation, which would be a side effect with limiting use in patients with brain injury or the need of intensive monitoring of cerebral perfusion pressure in this patients.

Study Sites (1)

Loading locations...

Similar Trials